Chagas Disease Recommendations for Solid-Organ Transplant Recipients and Donors

Transplantation. 2018 Feb;102(2S Suppl 2):S1-S7. doi: 10.1097/TP.0000000000002019.

Authors

Lígia Camera Pierrotti¹, Noemia Barbosa Carvalho¹, Jimena Prieto Amorin², Julio Pascual³, Camille N Kotton⁴, Rogelio López-Vélez⁵

Affiliations

¹ Infectious Diseases Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil.
² Catedra de Enfermedades Infecciosas, Facultad de Medicina-UDeLaR/Universidad de la República, Montevideo, Uruguay.
³ Nephrology Department and Kidney Transplantation Program Hospital del Mar, Universit at Autónoma Barcelona, Spain.
⁴ Infectious Diseases Division, Massachusetts General Hospital, Boston, MA.
⁵ National Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramón y Cajal University Hospital, Madrid, Spain.

PMID: 29381572
DOI: 10.1097/TP.0000000000002019

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antiparasitic Agents / adverse effects
Antiparasitic Agents / therapeutic use*
Chagas Disease / diagnosis
Chagas Disease / drug therapy*
Chagas Disease / parasitology
Chagas Disease / transmission
Donor Selection / methods*
Donor Selection / standards
Host-Parasite Interactions
Humans
Immunocompromised Host
Immunosuppressive Agents / adverse effects
Organ Transplantation / adverse effects
Organ Transplantation / methods*
Organ Transplantation / standards
Practice Guidelines as Topic
Risk Assessment
Risk Factors
Tissue Donors*
Transplant Recipients*
Treatment Outcome
Trypanosoma cruzi / drug effects*
Trypanosoma cruzi / isolation & purification
Trypanosoma cruzi / pathogenicity

Substances

Antiparasitic Agents
Immunosuppressive Agents